Recognition for quality patient care

  • Accredited Level II Trauma Center (American College of Surgeons)
  • Level I STEMI Center; Idaho Time Sensitive Emergency System
  • Level II Stroke Center; Idaho Time Sensitive Emergency System
  • Only hospital in Idaho designated as "Expert" for Pediatric Care Readiness (Idaho Emergency Medical Services for Children, 2024)
  • Primary Stroke Center certified by The Joint Commission
  • Only radiation oncology center in Idaho accredited by the American College of Radiology
  • Patient Safety Excellence Award (Healthgrades, 2024)
  • Get With The Guidelines® Stroke Gold Plus Quality Achievement Award (2024, 2023, 2022, 2021, 2020)
  • 50 Top Cardiovascular Hospital (PINC AI, 2024)
  • Chest Pain Center with Primary PCI Accreditation (American College of Cardiology, 2022)
  • Top 50 Hospital for Cardiovascular Care, two years in a row (IBM Watson Health, 2021, 2020)
  • "Best Maternity Care Hospitals," Newsweek (2022, 2021, 2020)
  • Designated "Silver" for Chest Pain MI Registry (American College of Cardiology, 2020)
  • Mission: Lifeline® Gold Plus Receiving Quality Achievement Award for STEMI care (2019)
  • HCA “Unit of Distinction”, ranking #1 out of 185 ER’s in HCA Healthcare (2019)
  • “Bronze Safe Sleep Hospital” by the National Safe Sleep Hospital Certification Program (2019)
  • Mission: Lifeline Bronze Certificate for non-STEMI care (2018)
  • Coronary Intervention Excellence Award™, placing it among the Top 10 percent in the country for this area of patient care (Healthgrades 2016)
  • Only hospital in the region to achieve three accreditations for heart care: Atrial-Fibrillation with EPS, Chest Pain and Heart Failure (ACC Accreditation Services 2016)

Eastern Idaho Regional Medical Center (EIRMC) offers the most complete stroke care in the region. Time is brain! Early recognition of stroke symptoms and intervention are essential to saving life and sustaining current daily living status. The quicker the patient arrives to the hospital for possible stroke, the more options that may be available.

EIRMC offers a multitude of stroke interventions including intravenous medication, endovascular and neurosurgical procedures. Some of exceptional care provided by our multidisciplinary stroke team is illustrated below.

Tenecteplase, a medication administered intravenously, should be administered within 60 minutes of patient arrival to the emergency department. This is called the door to needle. The American Heart Association (AHA) national benchmark for administering tenecteplase within 60 minutes is 85%. EIRMC exceeds that year after year.

EIRMC raised the bar with an organizational goal to administer tenecteplase within 45 minutes of patient arrival. The AHA national benchmark for administering tenecteplase within 45 minutes is 75%. Currently, EIRMC’s door to needle median is 31 minutes, far surpassing the national standard!

In addition to tenectplase, EIRMC offers thrombectomy, a procedure performed by a skilled team of interventional radiologists and nurses. Door to first pass measures the success rate of restoring blood flow to the brain on the first attempt. The goal is to restore blood flow within 120 minutes from the time the patient arrives to the emergency department. The AHA national benchmark for door to first pass within 120 minutes is 50%. EIRMC’s team continues to exceed this benchmark.

The thrombolysis in cerebral infarction (TICI) score is indicative of successful restoration of blood flow following a thrombectomy. This is important for neurological improvement and recovery. The AHA national benchmark is 50% for a TICI 2b or 3. EIRMC exceeds the national benchmark.

References:
American Heart Association. (2024). Get with the Guidelines Stroke Recognition Criteria.